The Retrobulbar Spot Sign and Prominent Middle Limiting Membrane as Prognostic Markers in Non-Arteritic Retinal Artery Occlusion.
central retinal artery occlusion
imaging
optical coherence tomography
prognosis
sudden vision loss
visual acuity
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
18 Jan 2021
18 Jan 2021
Historique:
received:
13
11
2020
revised:
11
12
2020
accepted:
14
01
2021
entrez:
22
1
2021
pubmed:
23
1
2021
medline:
23
1
2021
Statut:
epublish
Résumé
Central retinal artery occlusion (CRAO) is characterized by the sudden, painless loss of vision. Typical sonographic and optic coherence tomography (OCT) findings are a retrobulbar spot sign and prominent middle limiting membrane (p-MLM) sign. It remains uncertain whether the retrobulbar spot sign alone or coinciding with the appearance of p-MLM sign is a prognostic marker for visual acuity and the development of secondary retinal ischemia after CRAO. In our prospective cohort study, we included patients with a non-arteritic central artery occlusion < 4 weeks. We examined the following parameters at prespecified time points: ultrasound examination of orbital cavity, Spectral Domain-OCT examination, visual acuity test, and fundoscopy and ultra-widefield angiography to diagnose retinal vascularization. The presence of p-MLM sign in SD-OCT after CRAO was accompanied by significantly better vision during the first four weeks (2.3 (IQR 0.75) vs. 2.6 (IQR 0.33);
Identifiants
pubmed: 33477523
pii: jcm10020338
doi: 10.3390/jcm10020338
pmc: PMC7831102
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Neuroimaging. 2015 Mar-Apr;25(2):251-256
pubmed: 24641564
Invest Ophthalmol Vis Sci. 2006 Mar;47(3):1236-40
pubmed: 16505064
Stroke. 2011 Aug;42(8):2229-34
pubmed: 21757667
Semin Ophthalmol. 2017;32(1):125-133
pubmed: 27780399
Eye (Lond). 2010 Apr;24(4):678-81
pubmed: 19521436
Retina. 2013 Nov-Dec;33(10):2110-7
pubmed: 23594722
Lancet Neurol. 2014 Apr;13(4):429-38
pubmed: 24646875
Graefes Arch Clin Exp Ophthalmol. 2009 Jan;247(1):137-42
pubmed: 18766368
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
Stroke. 2015 Aug;46(8):2322-4
pubmed: 26111890
PLoS One. 2017 Aug 3;12(8):e0181766
pubmed: 28771491
Ophthalmology. 2015 Sep;122(9):1881-8
pubmed: 26231133
BMC Ophthalmol. 2019 Jul 10;19(1):147
pubmed: 31291918
Eye (Lond). 2020 Apr;34(4):683-689
pubmed: 31527762
Mayo Clin Proc. 2019 Feb;94(2):236-241
pubmed: 30711121
Retina. 2014 Jun;34(6):1132-41
pubmed: 24378425
Ann Eye Sci. 2018 Jun;3:
pubmed: 30198015
J Neuroophthalmol. 2018 Sep;38(3):328-333
pubmed: 29369960
N Engl J Med. 1991 Aug 15;325(7):445-53
pubmed: 1852179
Ophthalmology. 2010 Jul;117(7):1367-75.e1
pubmed: 20609991
J Neuroophthalmol. 2007 Sep;27(3):215-30
pubmed: 17895823
Stroke. 2020 Mar;51(3):800-807
pubmed: 31951154
Ultraschall Med. 2012 Dec;33(7):E263-E267
pubmed: 23023446
Ophthalmology. 2017 Feb;124(2):P120-P143
pubmed: 27742458
Asia Pac J Ophthalmol (Phila). 2018 Jul-Aug;7(4):235-241
pubmed: 29717825
Retina. 2011 Apr;31(4):730-7
pubmed: 21242861
J Ultrasound Med. 2020 Jan;39(1):197-202
pubmed: 31228289
Stroke. 2019 Sep;50(9):e253-e256
pubmed: 31449481
Am J Ophthalmol. 2005 Sep;140(3):376-91
pubmed: 16138997